FdaApplication
NDA 021455
Identifiers
- fda_app_no: NDA021455
Properties
| Property | Value |
|---|---|
| applicant_name | HOFFMANN LA ROCHE INC |
| application_type | NDA |
| approval_date | 2003-05-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BONIVA | IBANDRONATE SODIUM | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| BONIVA | IBANDRONATE SODIUM | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products